Stock listing
OTC:GNMSF Genmab A/S Stock
US listing (OTC) of Genmab A/S · home listing Copenhagen:GMAB
Follow Genmab A/S into a list and get an email when it puts out news.
Share price · OTC:GNMSF
$496.57 USD -7.17 (-1.4%)
Close on Nov 20, 2026
- Day range
- $495.75 – $497.69 USDNov 20, 2026
- Volume
- 6 sharesNov 20, 2026
- Market cap
- $30.53B USDAt the close on Nov 20, 2026 · price × 61.49M shares outstanding
- 52-week range
- $232.34 – $581.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.08M USDMedian day 100 shares · 27 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Copenhagen:GMAB · Home | 3,469.00 DKK | -27.00 (-0.8%) | 123,938 | 3,497.00 | 3,515.00 | 3,465.00 | 3,496.00 | Close on Nov 20, 2026 |
| NASDAQ:GMAB | $50.60 USD | -0.75 (-1.5%) | 2,793,203 | $51.57 | $51.72 | $50.24 | $51.35 | Close on Nov 20, 2026 |
| OTC:GNMSF | $496.57 USD | -7.169 (-1.4%) | 6 | $497.25 | $497.69 | $495.75 | $503.74 | Close on Nov 20, 2026 |
| Frankfurt:GE9 | €464.50 EUR | -0.20 (0.0%) | — | €464.50 | €464.50 | €464.50 | €464.70 | Close on Nov 20, 2026 |
| Dusseldorf:GE9 | €460.50 EUR | -8.10 (-1.7%) | — | €464.70 | €468.20 | €460.50 | €468.60 | Close on Nov 20, 2026 |
| Frankfurt:GE91 | €46.60 EUR | 0.00 (0.0%) | — | €46.40 | €46.60 | €46.40 | €46.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:GNMSF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $526.00 | -12.00 | -2.2% | $526.00 | $526.00 | $526.00 | 100 | |
| $538.00 | -8.00 | -1.5% | $538.00 | $538.00 | $538.00 | 100 | |
| $546.00 | -17.82 | -3.2% | $574.50 | $574.50 | $546.00 | 100 | |
| $563.82 | 0.00 | 0.0% | $563.82 | $563.82 | $563.82 | 0 | |
| $563.82 | 0.00 | 0.0% | $563.82 | $563.82 | $563.82 | 0 | |
| $563.82 | +8.52 | +1.5% | $572.00 | $578.00 | $563.82 | 2,100 | |
| $555.30 | -24.70 | -4.3% | $569.70 | $569.70 | $551.00 | 20,700 | |
| $580.00 | +140.95 | +32.1% | $445.00 | $581.00 | $445.00 | 21,300 | |
| $439.05 | -8.50 | -1.9% | $439.05 | $439.05 | $439.05 | 100 | |
| $447.55 | 0.00 | 0.0% | $447.55 | $447.55 | $447.55 | 0 | |
| $447.55 | +59.03 | +15.2% | $400.00 | $447.55 | $395.75 | 12,300 | |
| $388.52 | 0.00 | 0.0% | $388.52 | $388.52 | $388.52 | 0 | |
| $388.52 | 0.00 | 0.0% | $388.52 | $388.52 | $388.52 | 0 | |
| $388.52 | +10.52 | +2.8% | $388.00 | $390.00 | $388.00 | 900 | |
| $378.00 | +11.00 | +3.0% | $378.00 | $378.00 | $378.00 | 100 | |
| $367.00 | 0.00 | 0.0% | $367.00 | $367.00 | $367.00 | 0 | |
| $367.00 | 0.00 | 0.0% | $367.00 | $367.00 | $367.00 | 0 | |
| $367.00 | 0.00 | 0.0% | $367.00 | $367.00 | $367.00 | 0 | |
| $367.00 | 0.00 | 0.0% | $367.00 | $367.00 | $367.00 | 0 | |
| $367.00 | 0.00 | 0.0% | $367.00 | $367.00 | $367.00 | 0 | |
| $367.00 | -9.00 | -2.4% | $367.00 | $367.00 | $367.00 | 100 | |
| $376.00 | 0.00 | 0.0% | $376.00 | $376.00 | $376.00 | 0 | |
| $376.00 | 0.00 | 0.0% | $376.00 | $376.00 | $376.00 | 0 | |
| $376.00 | -20.97 | -5.3% | $382.60 | $384.00 | $376.00 | 37,200 | |
| $396.97 | +41.97 | +11.8% | $355.00 | $396.97 | $351.17 | 1,700 | |
| $355.00 | 0.00 | 0.0% | $355.00 | $355.00 | $355.00 | 0 | |
| $355.00 | 0.00 | 0.0% | $355.00 | $355.00 | $355.00 | 0 | |
| $355.00 | 0.00 | 0.0% | $355.00 | $355.00 | $355.00 | 0 | |
| $355.00 | 0.00 | 0.0% | $355.00 | $355.00 | $355.00 | 0 | |
| $355.00 | +2.00 | +0.6% | $355.00 | $355.00 | $355.00 | 100 | |
| $353.00 | +6.24 | +1.8% | $353.00 | $353.00 | $353.00 | 100 | |
| $346.76 | +8.01 | +2.4% | $346.76 | $346.76 | $346.76 | 800 | |
| $338.75 | -11.25 | -3.2% | $338.75 | $338.75 | $338.75 | 100 | |
| $350.00 | +7.00 | +2.0% | $350.00 | $350.00 | $350.00 | 100 | |
| $343.00 | 0.00 | 0.0% | $343.00 | $343.00 | $343.00 | 0 | |
| $343.00 | 0.00 | 0.0% | $343.00 | $343.00 | $343.00 | 0 | |
| $343.00 | +2.00 | +0.6% | $343.00 | $343.00 | $343.00 | 200 | |
| $341.00 | +2.02 | +0.6% | $342.00 | $342.00 | $341.00 | 700 | |
| $338.98 | +9.73 | +3.0% | $336.25 | $338.98 | $336.25 | 200 | |
| $329.25 | 0.00 | 0.0% | $329.25 | $329.25 | $329.25 | 0 | |
| $329.25 | 0.00 | 0.0% | $329.25 | $329.25 | $329.25 | 0 | |
| $329.25 | 0.00 | 0.0% | $329.25 | $329.25 | $329.25 | 0 | |
| $329.25 | 0.00 | 0.0% | $329.25 | $329.25 | $329.25 | 0 | |
| $329.25 | 0.00 | 0.0% | $329.25 | $329.25 | $329.25 | 0 | |
| $329.25 | -8.75 | -2.6% | $329.25 | $329.25 | $329.25 | 100 | |
| $338.00 | 0.00 | 0.0% | $338.00 | $338.00 | $338.00 | 148 | |
| $338.00 | 0.00 | 0.0% | $338.00 | $338.00 | $338.00 | 0 | |
| $338.00 | 0.00 | 0.0% | $338.00 | $338.00 | $338.00 | 0 | |
| $338.00 | 0.00 | 0.0% | $338.00 | $338.00 | $338.00 | 0 | |
| $338.00 | 0.00 | 0.0% | $338.00 | $338.00 | $338.00 | 148 | |
| $338.00 | +1.00 | +0.3% | $332.64 | $338.00 | $332.64 | 100 | |
| $337.00 | 0.00 | 0.0% | $337.00 | $337.00 | $337.00 | 0 | |
| $337.00 | +9.30 | +2.8% | $337.00 | $337.00 | $337.00 | 100 | |
| $327.70 | -9.30 | -2.8% | $327.70 | $327.70 | $327.70 | 100 | |
| $337.00 | +2.00 | +0.6% | $337.00 | $337.00 | $337.00 | 300 | |
| $335.00 | +15.00 | +4.7% | $335.00 | $335.00 | $335.00 | 40,000 |
- Ticker
- OTC:GNMSF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 18, 2026
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Latest earnings call · Nov 5, 2026
Genmab (Copenhagen:GMAB) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 19 slides
Calls
Replays
Genmab (Copenhagen:GMAB) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 12:00 PM ET
Watch TranscriptGenmab (Copenhagen:GMAB) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 12:00 PM ET
Watch TranscriptGenmab (Copenhagen:GMAB) Q1 2026 Earnings Call
Thu, May 07, 2026 · 12:00 PM ET
Watch Transcript
Latest news
Interim Report for the First Nine Months of 2026
Nov 5, 2026
Closed $538.00 (-1.5%) on Nov 5, 2026
Genmab A/S Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer
Oct 3, 2026
Closed $396.97 (+11.8%) on Oct 5, 2026
Notice to Convene an Extraordinary General Meeting of Genmab A/S
Sep 8, 2026
Closed $329.25 (0.0%) on Sep 8, 2026
Interim Report for the First Half of 2026
Aug 6, 2026
Closed $295.00 (+1.7%) on Aug 6, 2026
Genmab Announces Financial Results for the First Half of 2026
Aug 6, 2026
Closed $295.00 (+1.7%) on Aug 6, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
Jul 15, 2026
Closed $285.85 (0.0%) on Jul 15, 2026
Financings
6.250% senior secured notes due 2032
Dec 3, 2025
Closed: US$1.5B raised
Use of proceeds: With new credit facilities and cash, to fund the pending acquisition of Merus N.V. and related fees and expenses
Announced Nov 10, 2025 · Update Nov 10, 2025 · Update Nov 18, 2025 · Closed Dec 3, 2025
7.250% senior unsecured notes due 2033
Dec 3, 2025
Closed: US$1B raised
Use of proceeds: With new credit facilities and cash, to fund the pending acquisition of Merus N.V. and related fees and expenses
Announced Nov 10, 2025 · Update Nov 10, 2025 · Update Nov 18, 2025 · Closed Dec 3, 2025
Decks
Q2 2026 Earnings Presentation
Earnings · 19 slides · Aug 6, 2026
Technical Presentation (June 2026)
Technical · 20 slides · June 2026
Q1 2026 Earnings Presentation
Earnings · 18 slides · May 7, 2026
FY2025 Earnings Presentation
Earnings · 19 slides · Feb 17, 2026
Genmab A/S on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 45 in the last 12 months · 73 in all · newest Nov 18, 2026 · oldest 2025
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
- Decks
- 36 decks · latest Aug 6, 2026
Where Genmab A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Copenhagen:GMAB · Home listing | Copenhagen | Denmark | DKK |
| NASDAQ:GMAB | NASDAQ | United States | USD |
| gettex:GE9 | gettex | Germany | EUR |
| LSIN:0MGB | LSIN | United Kingdom | DKK |
| OTC:GNMSF · This page | OTC | United States | USD |
| Frankfurt:GE9 | Frankfurt | Germany | EUR |
| Xetra:GE9 | Xetra | Germany | EUR |
| Tradegate:GE9 | Tradegate | Germany | EUR |
| VIE:GMAB | Vienna | Austria | EUR |
| LS Exchange:565131 | LS Exchange | Germany | EUR |
| Aquis:GMABC | Aquis | United Kingdom | DKK |
| Lang & Schwarz:565131 | Lang & Schwarz | Germany | EUR |
| BMV:GMABN | BMV | Mexico | MXN |
| BX Swiss:GMAB | BX Swiss | Switzerland | CHF |
| gettex:GE91 | gettex | Germany | EUR |
| Aquis:GMABC | Aquis | United Kingdom | DKK |
| Hamburg:GE9 | Hamburg | Germany | EUR |
| Turquoise:GMABC | Turquoise | United Kingdom | DKK |
| Dusseldorf:GE9 | Dusseldorf | Germany | EUR |
| Hanover:GE9 | Hanover | Germany | EUR |
| Stuttgart:GE9 | Stuttgart | Germany | EUR |
| BIVA:GMABN | BIVA | Mexico | MXN |
| BMV:GMAB1N | BMV | Mexico | MXN |
| Lang & Schwarz:A1WZYB | Lang & Schwarz | Germany | EUR |
| Munich:GE9 | Munich | Germany | EUR |
| Stuttgart:GE91 | Stuttgart | Germany | EUR |
| BOATS:GMAB | BOATS | United States | USD |
| Dusseldorf:GE91 | Dusseldorf | Germany | EUR |
| Frankfurt:GE91 | Frankfurt | Germany | EUR |
| LS Exchange:A1WZYB | LS Exchange | Germany | EUR |
| Munich:GE91 | Munich | Germany | EUR |
| Tradegate:GE91 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Genmab A/S.